scispace - formally typeset
Search or ask a question

What are theories used to explain why SSRIs and SNRIs are effective at treating Social anxiety disorder? 


Best insight from top research papers

SSRIs and SNRIs are effective in treating Social Anxiety Disorder (SAD) due to their ability to induce anxiolytic effects by attenuating neural activity in specific amygdala subregions, particularly the left basolateral and right ventrolateral amygdala . These medications alter brain pathways, leading to improved emotion regulation and reduced anxiety expression . Additionally, higher doses of SSRIs within the therapeutic range are associated with greater treatment benefits for SAD, especially in terms of symptom improvement and treatment response likelihood . Furthermore, the combination of SSRIs with cognitive-behavioral therapy (CBT) has shown to enhance clinical outcomes in SAD, with decreased amygdala reactivity playing a crucial role in the anxiolytic treatment response .

Answers from top 5 papers

More filters
Papers (5)Insight
SSRIs and SNRIs are effective in treating Social Anxiety Disorder due to their impact on brain reactivity and connectivity, enhancing extinction learning, and improving the efficacy of cognitive-behavioral therapy.
SSRIs and SNRIs are effective in treating social anxiety disorder due to their overall symptom improvement, likelihood of treatment response, and dose-response relationship, as indicated in the meta-analysis.
Not addressed in the paper.
SSRIs and SNRIs are effective in treating Social Anxiety Disorder by modulating amygdala-frontal couplings, enhancing emotion regulation, and reducing anxiety expression through shared neuromodulatory pathways.
SSRIs and SNRIs treat social anxiety disorder by affecting dopamine signaling, psychological factors, and serotonin transporter blockade, with dopamine playing a crucial role in symptom improvement.

Related Questions

How does SSRI treat anxiety disorder?5 answersSelective serotonin reuptake inhibitors (SSRIs) are effective in treating anxiety disorders by reducing fear expression, facilitating extinction learning, and improving overall symptomatology. Studies show that SSRIs significantly reduce contextual fear expression and aid in cue extinction learning. In pediatric anxiety disorders, SSRIs are superior to placebo and effectively treat symptoms, with a low risk of serious adverse events. SSRIs are recommended as first-line treatment for panic disorder due to their favorable adverse effect profile. Additionally, SSRIs and serotonin norepinephrine reuptake inhibitors (SNRIs) are effective in treating anxiety disorders, with higher doses of SSRIs associated with greater symptom improvement. In patients with anxious depression, SSRIs like escitalopram, desvenlafaxine, and vortioxetine show similar efficacy and tolerability in reducing anxiety and depressive symptoms.
Why do SSRIs treat eating disorders?5 answersSelective serotonin reuptake inhibitors (SSRIs) are effective in treating eating disorders due to their impact on serotonin levels, which play a crucial role in regulating mood and appetite. Studies have shown that reduced serotonin activity is linked to cognitive and mood disturbances associated with eating disorders, making SSRIs a viable treatment option. SSRIs like sertraline and fluoxetine have been found to reduce binge eating frequency, severity of psychopathology, and body weight in patients with Binge Eating Disorder (BED). Additionally, SSRIs have been shown to effectively reduce bulimic crisis, purging episodes, and binge eating severity in patients with eating disorders, leading to improved outcomes and quality of life. Therefore, SSRIs are recommended for treating eating disorders due to their ability to modulate serotonin levels and alleviate symptoms associated with these conditions.
How can social anxiety be treated?5 answersSocial anxiety can be treated using various therapeutic approaches. Cognitive-behavioral therapy (CBT) is one of the most effective treatments for social anxiety disorder (SAD). CBT typically includes techniques such as exposure to avoided situations, cognitive restructuring, assertiveness training, and social skills training. Additionally, mindfulness and acceptance-based therapies (MABT) have been integrated into treatment programs for SAD, combining mindfulness, experiential, acceptance, and cognitive defusion exercises with traditional CBT techniques. Digital CBT programs, such as Alena, have also shown promise in the treatment of social anxiety, providing targeted therapy modules for cognitive dysfunction associated with SAD. Integrative systemic and family therapy (ISFT) is another approach that has been developed specifically for SAD, incorporating solution-focused language, social network diagnostics, and genogram work. Overall, the treatment of social anxiety involves a combination of cognitive, behavioral, and systemic interventions, tailored to the individual's needs and preferences.
Is cognitive behavioral therapy (CBT) effective in the treatment of social anxiety?4 answersCognitive behavioral therapy (CBT) has been shown to be effective in the treatment of social anxiety. Studies have demonstrated that CBT can lead to significant reductions in social anxiety symptoms, fear of negative evaluation, self-focused attention, and depressive symptoms. Additionally, CBT has been found to be safe, acceptable, and promising in terms of rapid efficacy when delivered through digital platforms. Furthermore, a combination of CBT and mindfulness therapy has been found to be more effective in reducing social anxiety compared to CBT alone. A systematic review of clinical trials also supports the positive effects of CBT in reducing anxiety symptoms in children and adolescents. Overall, these findings suggest that CBT is an effective treatment option for social anxiety across different age groups and delivery formats.
What is the role of SSRIs in the treatment of anxiety?5 answersSelective serotonin reuptake inhibitors (SSRIs) have been widely used for the treatment of anxiety disorders in children, adolescents, and adults. They have shown to be effective and safe in short-term treatment of anxiety in young people, both as a standalone treatment and in combination with cognitive-behavioral therapy (CBT). SSRIs have also been recognized as the cornerstone for the treatment of depression, anxiety, obsessive-compulsive disorder, and panic disorder in various age groups. However, there are still outstanding questions regarding the effects of SSRIs in youth, and further research is needed to understand the mechanisms of action and the long-term effects of SSRIs in children and adolescents. It is important to consider the comparative effectiveness of anxiety treatments and to evaluate the degree of suicide risk associated with SSRIs. Overall, SSRIs play a significant role in the treatment of anxiety disorders, but more research is needed to fully understand their benefits and risks.
What are the most effective therapies for social anxiety and social phobia?5 answersCognitive behavioral therapy (CBT) and pharmacotherapy have been consistently shown to be effective treatments for social anxiety disorder and social phobia. CBT focuses on identifying and changing negative thought patterns and behaviors associated with social anxiety, while pharmacotherapy typically involves the use of selective serotonin reuptake inhibitors (SSRIs). These treatment modalities have been found to provide equivalent outcomes on average. Other psychotherapeutic interventions that have shown promise include social skills training, interpersonal therapy, acceptance and commitment therapy, and psychodynamic therapy. However, it is important to note that some common practices have been found to be ineffective, and there are still some treatment approaches that have yet to be empirically evaluated. Overall, CBT and pharmacotherapy, particularly SSRIs, are considered the most effective therapies for social anxiety and social phobia.

See what other people are reading

What can mitigate the effects of prenatal stress in rats?
4 answers
Chronic prenatal stress (PS) in rats can lead to lasting behavioral and neurochemical alterations. However, interventions such as pharmacological treatments with antidepressants like agomelatine and fluoxetine have shown promise in mitigating the effects of prenatal stress. These treatments have been found to reverse the reduction in glutamate release in the ventral hippocampus, a region associated with stress and emotions, and improve anxiety-like behavior and social memory in prenatally stressed rats. Additionally, exposure to variable frequency ultrasound during pregnancy has been shown to influence offspring development and behavior, highlighting the potential of this exposure as a model for prenatal stress and its effects. Furthermore, an early dietary intervention in dams, such as a methyl donor supplemented diet, has been found to reverse cognitive impairments induced by prenatal stress in offspring, suggesting a potential avenue for mitigating the long-term effects of prenatal stress.
Encontre artigos cientifico com esse tema :Stress and anxiety in young people who combine studies?
5 answers
Research on stress and anxiety in young individuals combining studies reveals significant findings. Studies show that youth with chronic medical conditions (CMCs) have a higher prevalence of anxiety disorders compared to the general population, potentially impacting disease-related outcomes. However, the efficacy of psychobiotics in treating anxiety in youth remains inconclusive, with limited evidence supporting their use. Additionally, young people's perceptions of anxiety and depression play a crucial role in treatment engagement and effectiveness, emphasizing the need to incorporate their illness beliefs into clinical formulations for better outcomes. Furthermore, investigations into the relationship between anxiety and cannabis use in adolescents and young adults suggest varying associations, with some studies finding a positive link between anxiety and cannabis use. Overall, these studies shed light on the complex interplay between stress, anxiety, and academic pursuits in young individuals.
Can cognitive-behavioral therapy (CBT) be an effective treatment for both anxiety and eating disorders?
5 answers
Cognitive-behavioral therapy (CBT) has shown effectiveness in treating both anxiety disorders and eating disorders. Research indicates that CBT can effectively reduce symptoms of social anxiety disorder (SAD), depression, and psychological distress. Additionally, CBT has been found to be beneficial in addressing anxiety-related disorders in adults, including post-traumatic stress disorder (PTSD). Furthermore, CBT is recognized as an evidence-based intervention for psychological disorders, focusing on reducing avoidance behaviors and modifying cognitive biases, which are crucial aspects in treating anxiety problems. Moreover, studies have shown that Enhanced Cognitive Behavior Therapy (CBT-E) can lead to weight gain and improvement in psychopathology for patients with anorexia nervosa (AN). Therefore, CBT emerges as a promising treatment approach for both anxiety and eating disorders, offering structured and goal-oriented interventions to address symptoms effectively.
Corona pandemic influence on social phobia in children?
5 answers
The COVID-19 pandemic has significantly impacted children's mental health, particularly those vulnerable to anxiety disorders like social phobia. Studies have shown that the pandemic and related isolation measures have exacerbated separation anxiety and social phobia in children. The prevalence of anxiety disorders, including social phobia, has increased during the pandemic, leading to elevated levels of anxiety among children. The shift in social interactions and the disruption of daily routines due to the pandemic have contributed to the intensification of social anxiety among youths. The psychological burden on children, coupled with limited access to specialized healthcare services, has further exacerbated social phobia during the pandemic. Overall, the COVID-19 pandemic has had a negative impact on children's mental health, increasing the prevalence of social phobia and other anxiety disorders.
Does PTSD lead to anxiety?
5 answers
Yes, PTSD can lead to anxiety. Individuals with PTSD often experience symptoms of anxiety, such as fear, hyperarousal, and distress upon trauma reminders. Moreover, PTSD is frequently associated with higher levels of anxiety and depression compared to non-PTSD groups. Cognitive distortions, which are prevalent in PTSD, contribute to increased anxiety levels in individuals with PTSD. Additionally, trauma-informed beliefs, including anxiety sensitivity (AS), tend to decrease during PTSD treatment, indicating a link between PTSD and anxiety-related beliefs. Therefore, PTSD not only involves anxiety symptoms but also exacerbates anxiety levels, highlighting the intricate relationship between PTSD and anxiety disorders.
What is the rol of dopamine receptors genes in major depression?
10 answers
The role of dopamine receptor genes in major depression has been a subject of extensive research, with studies exploring various aspects of their involvement in the pathophysiology of the disorder. The dopamine D4 receptor gene (DRD4) has been investigated for its expression levels in patients with major depressive disorder (MDD), revealing significantly decreased D4DR mRNA levels in untreated depressed patients, which returned to control levels following treatment with paroxetine, suggesting a potential role of this receptor in the central dopaminergic function in MDD. Additionally, functional variants of the DRD4 gene have been associated with depressive symptomatology, particularly delusional symptoms in mood disorder subjects, indicating a possible genetic predisposition. Research on the dopamine D3 receptor gene (DRD3) variation has shown some impact on the response to electroconvulsive therapy (ECT) in treatment-resistant major depression, potentially mediated by alteration of striatal engagement during the processing of emotionally rewarding stimuli. The dopamine 2 receptor gene (DRD2) polymorphism has also been implicated in MDD susceptibility and the onset-time of antidepressant response, suggesting a role in the disorder's development and treatment outcomes. Moreover, a study on the polygenic effects in the dopamine pathway on the reward network in MDD patients found associations within the nucleus accumbens functional connectivity network, highlighting the contribution of dopamine multilocus genetic profile to reward network and anxious depression in MDD patients. A variant downstream of DRD3 has been significantly associated with MDD-nicotine dependence co-morbidity, suggesting that nicotine dependence may potentiate the influence of the DRD3 genetic variant on MDD. Genetic interactions among regulatory regions of dopamine receptors, specifically between DRD1 and DRD2, have been identified to affect the level of manifestation of depressive symptoms, indicating an imbalance of D1-D2 heteromers and modulation of cognitive processes. Lastly, the involvement of dopamine receptors in depression is further supported by research on the molecular, cellular, and circuit mechanisms of dopamine and its receptors, providing new directions for understanding the etiology and treatment of depression. In summary, dopamine receptor genes play a multifaceted role in major depression, influencing susceptibility, symptomatology, treatment response, and the disorder's underlying neurobiological mechanisms. These findings underscore the complexity of dopamine's involvement in MDD and highlight potential targets for therapeutic intervention.
Do SSRIs reduce bingeing and vomiting in bulimia?
5 answers
Yes, SSRIs like fluoxetine have shown efficacy in reducing binge eating episodes in bulimia nervosa (BN) patients. Studies have highlighted that fluoxetine significantly decreases the frequency of binge eating and is associated with the greatest reduction in depression scores compared to placebo. Additionally, the pharmacological treatment of BN primarily involves SSRIs due to their impact on the serotonin system, which is implicated in the pathogenesis of BN. While the exact mechanisms are not fully understood, SSRIs are considered modestly effective in reducing binge eating over the short and long term in both BN and binge eating disorder (BED) patients. Therefore, SSRIs, particularly fluoxetine, are a viable option for reducing binge eating episodes in individuals with bulimia.
Who adolescents stay with and anxiety?
5 answers
Adolescents often stay with their parents or caregivers. Positive interactions with adults at home can lead to positive outcomes for adolescents, including emotional stability and better academic performance. Anxiety disorders are prevalent among adolescents, with a significant percentage experiencing anxiety-related issues. Factors like parental relationships and family dynamics can influence the development of anxiety in adolescents. Studies have shown that anxiety disorders are common among school children, with various subtypes like generalized anxiety disorder, panic disorder, and social phobia being identified. Additionally, the prevalence of anxiety disorders is higher in girls compared to boys. Therefore, adolescents' living environments, family relationships, and gender can all play a role in the development and prevalence of anxiety disorders.
What is the current state of SSRI use in Africa?
5 answers
The current state of SSRI (Selective Serotonin Reuptake Inhibitor) use in Africa is evolving. Studies have shown that antidepressant therapy, including SSRIs like sertraline, plays a crucial role in managing depressive disorders prevalent in HIV-infected individuals in Africa. While the efficacy of antidepressants has been debated, controlled clinical trials continue to demonstrate their benefits in treating depression. Moreover, the recent establishment of the African Federation of Operational Research Societies signifies progress in promoting operations research, including pharmacovigilance activities related to drug monitoring and reporting in Africa. Despite these advancements, there is still room for growth in SSRI utilization and pharmacovigilance efforts across the continent.
What is the rol of drd2 nd drd4 genes in major depression?
5 answers
The role of DRD2 and DRD4 genes in major depressive disorder (MDD) has been a subject of extensive research, given the complex genetic underpinnings of psychiatric disorders including MDD. The DRD2 gene, associated with the dopamine D2 receptor, has been implicated in the susceptibility to MDD and the response to antidepressant treatment. A study highlighted the potential influence of DRD2 polymorphism on MDD risk and the timing of antidepressant response, suggesting a role in both disease susceptibility and treatment efficacy. However, the genetic architecture of MDD involves interactions with environmental factors, as no single genetic variation has been identified to substantially increase depression risk on its own. On the other hand, the DRD4 gene, related to the dopamine D4 receptor, has been studied for its association with psychiatric disorders through mechanisms such as DNA methylation, which could influence gene expression and thus, disease phenotypes. Despite these associations, a study investigating the antidepressant activity of selective serotonin reuptake inhibitors (SSRIs) found no significant association between DRD4 (and DRD2) gene variants and treatment response, indicating that these genes may not play a major role in SSRI efficacy in their sample. Moreover, the interaction between genetic predispositions and environmental stressors has been explored, with findings suggesting that DRD2 polymorphism may moderate the effect of stressful life events on depressive symptoms, indicating a gene-environment interaction where certain genotypes may influence the vulnerability to depression under stress. However, another study did not support a major role for polymorphisms in the DRD2 and DRD4 genes in contributing to MDD susceptibility, although minor effects could not be precluded. In summary, while the DRD2 and DRD4 genes have been implicated in the pathophysiology of MDD through various mechanisms, including susceptibility, treatment response, and interaction with environmental stressors, the evidence suggests that their roles are complex and likely involve interactions with other genetic and environmental factors.
What are the most common gastrointestinal symptoms of anxiety?
5 answers
The most common gastrointestinal symptoms of anxiety include abdominal pain, diarrhea, bloating, constipation, nausea/vomiting, and loss of appetite. These symptoms are frequently reported in individuals with anxiety disorders, with a high prevalence in both adults and children. Anxiety can lead to functional gastrointestinal disorders (FGIDs), such as irritable bowel syndrome (IBS) and functional dyspepsia (FD), which are characterized by chronic or relapsing GI symptoms without identifiable structural abnormalities. Additionally, during stressful situations, there is a significant association between gastrointestinal complaints and difficulties in interpersonal relationships, further exacerbating the link between anxiety and gastrointestinal symptoms. Overall, the presence of gastrointestinal symptoms in individuals with anxiety underscores the importance of addressing both psychological and physical aspects in treatment approaches.